P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide
Publication
, Journal Article
McDonald, KL; Ha, W; Khasraw, M
Published in: Neuro-Oncology
April 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
April 2017
Volume
19
Issue
suppl_3
Start / End Page
iii27 / iii27
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McDonald, K. L., Ha, W., & Khasraw, M. (2017). P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide. Neuro-Oncology, 19(suppl_3), iii27–iii27. https://doi.org/10.1093/neuonc/nox036.096
McDonald, K. L., W. Ha, and M. Khasraw. “P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide.” Neuro-Oncology 19, no. suppl_3 (April 2017): iii27–iii27. https://doi.org/10.1093/neuonc/nox036.096.
McDonald KL, Ha W, Khasraw M. P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide. Neuro-Oncology. 2017 Apr;19(suppl_3):iii27–iii27.
McDonald, K. L., et al. “P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide.” Neuro-Oncology, vol. 19, no. suppl_3, Oxford University Press (OUP), Apr. 2017, pp. iii27–iii27. Crossref, doi:10.1093/neuonc/nox036.096.
McDonald KL, Ha W, Khasraw M. P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide. Neuro-Oncology. Oxford University Press (OUP); 2017 Apr;19(suppl_3):iii27–iii27.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
April 2017
Volume
19
Issue
suppl_3
Start / End Page
iii27 / iii27
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences